BMY has to be interested in Vical for A-7 data and vaccine herpes on and on, makes sense.
Dog melanoma and the whole 9 yards. This price is a steal as will be noted one year from now, SNY, GSK, Amgen. Merck , NVS . This small biotech has an easy 5 to 10 times buy out in my opinion. Way to much research and patent data to go any other way. I have no reason to believe Singer will keep on selling the total 10 million Vical shares at this price unless he can't think straight. I think he's a smart man and has a reason to write off a few million, not the total. IMP.